Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
US9555045B2 · kind B2 · utility
6Cited by
18References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2010 |
| Grant date | Jan 31, 2017 |
| Priority date | — |
| Expiry date | Mar 23, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/216
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition for use in treating corneal and conjunctival lesions, includes a prostaglandin F2alpha or analogue, in a therapeutic amount, the composition being in a form suitable for topical application on the ocular surface and is free of deleterious preservative. A method for treating surface ocular conditions in a patient in need thereof, includes administering an effective amount of the composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.